Voyager Therapeutics inks deal with Novartis
Voyager Therapeutics Inc has secured a license option agreement valued at potentially more than US$1.7bn with Swiss pharma group, Novartis.
Archives for March 8, 2022
One-stop-shop CDMO to support manufacturing of AAV-based product targeting Alzheimer’s disease
Finnish company, Biovian Oy, has been engaged by a South Korea biotechnology company to carry out process development and manufacturing of an AAV-based innovative drug candidate.
Flow Eighteen38 to double protein purification capacity
Flow Eighteen38, a protein sciences division created to facilitate and accelerate antibody characterization and protein purification projects, has announced a €5m ($5.58m) investment into its protein production and biophysical characterization...
Moderna to build mRNA manufacturing site in Kenya
mRNA pioneer Moderna has entered into a Memorandum of Understanding with the Government of the Republic of Kenya to establish an mRNA manufacturing facility in the country.